Drugs / Gallium-68 citrate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT02391025 | May 2015 → Jun 2023 | prostate cancer | Rahul Aggarwal | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gallium-68 citrate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02391025 ↗ |
| Modality | Diagnostic / imaging agent | “use of gallium-68 citrate PET” NCT02391025 ↗ |
| Route | Intravenous | “Given via IV at time of imaging” NCT02391025 ↗ |